Cdk2 Activators
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $51.00 | ||
A synthetic cytokinin mainly utilized in plant biology. It's been reported to induce Cdk2 activation in plant cells, likely through its role in promoting cell division and DNA replication. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Predominantly a Cdk inhibitor, its mechanism largely involves inhibiting cyclin-dependent kinases, including Cdk2. However, in specific cellular contexts or concentrations, it might indirectly modulate Cdk2 activation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Like Olomoucine, Roscovitine is primarily a Cdk inhibitor. Its nuanced effects on Cdk2 activation depend on the cellular context, but its primary mechanism involves inhibiting cyclin-dependent kinases. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, Okadaic acid can prevent the dephosphorylation of certain proteins, possibly including those involved in Cdk2 regulation, leading to altered Cdk2 activation. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Widely recognized for its role in adenosine receptor antagonism, caffeine also affects several kinases and phosphatases. Through these interactions, caffeine might indirectly modulate Cdk2 activation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
A tyrosine kinase inhibitor known to influence various cellular signaling pathways. Through its broad range of effects, Genistein could potentially modulate Cdk2 activity, although the connection is indirect. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
An anti-cancer drug causing DNA damage, thereby influencing cell cycle checkpoints. In response to DNA damage, cells might adjust Cdk2 activity to manage cell cycle progression. | ||||||
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $35.00 $86.00 $216.00 $427.00 | 8 | |
An alkaloid that induces G1 arrest. By affecting progression through the G1 phase of the cell cycle, Mimosine might indirectly modulate Cdk2 activity, which is crucial for the G1-to-S phase transition. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Primarily a cholesterol-lowering drug, Lovastatin can affect cell cycle progression. Its potential influence on Cdk2 is likely indirect, stemming from broader effects on cell cycle regulators. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Known to primarily target mTOR, Rapamycin has downstream effects on the cell cycle. By influencing mTOR and its associated pathways, Rapamycin might indirectly modulate Cdk2 activity. | ||||||